BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2008
View Archived Issues
Privigen pharmacokinetics and high infusion rate tolerability studied
Read More
New therapeutic options for hepatitis C described in recent patent literature
Read More
Recent patents report novel therapeutic agents for neurological disorders
Read More
VIA Pharmaceuticals completes enrollment for phase II carotid endarterectomy study
Read More
Seattle Genetics begins phase I trial of SGN-33 plus Revlimid in MDS patients
Read More
Tripep presents preliminary results from the ongoing ChronVac-C study
Read More
EpiCept announces EMEA opinion on Ceplene in AML
Read More
Cell Therapeutics completes enrollment for pixantrone phase III EXTEND trial in NHL
Read More
Recent Surface Logix patent imparts new treatment option for cardiovascular disorders
Read More
Abbott and Takeda to conclude TAP joint venture
Read More
IgG-hydrolyzing enzyme shows promise against autoimmune diseases
Read More
Neoprobe reports final phase II results with Lymphoseek
Read More
Japanese registration study of Soliris completes enrollment
Read More
Novel pandemic influenza vaccine effective against H7N7 virus
Read More
New phase Ib trial evaluates NPI-2358 for NSCLC
Read More
Amrubicin receives FDA orphan drug designation for small cell lung cancer
Read More
Novel alphav integrin inhibitor profiled at Johnson & Johnson
Read More
Anesiva initiates phase III Adlea trial for postsurgical pain
Read More
Array BioPharma files IND for ARRY-614 and initiates phase I clinical trial
Read More
Anacor announces positive results from phase IIa trial of AN-2728 in psoriasis patients
Read More
DiaMedica enrolls first patient in phase II human clinical trial for DM-83
Read More
Neuropharm commences phase II NPL-2009 trial in Fragile X syndrome
Read More
Rilonacept available in U.S. for cryopyrin-associated periodic syndromes
Read More
Single dose of Iomai patch with H5N1 flu vaccine achieves protective levels
Read More
Statistical significance not shown on primary endpoint in SinuNase lavage trial
Read More